MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAINT PAUL, Minn., Aug. 29, 2013 -- /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2013.

Third Quarter Highlights:

Robust third quarter revenue of $7.9 million, a 15% increase over the fiscal 2012 third quarter. Sequential quarterly revenue growth of 4.8% from the fiscal 2013 second quarter

Help employers find you! Check out all the jobs and post your resume.

Back to news